BCRX
vs
EXAS
BCRX
EXAS
Over the past 12 months, BCRX has underperformed EXAS, delivering a return of +24% compared to the EXAS's +4 203% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
BCRX
EXAS
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
|
9.33
USD
|
|||||
|
Exact Sciences Corp
NASDAQ:EXAS
|
1 862.66
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
BCRX, EXAS
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
BioCryst Pharmaceuticals Inc
Revenue
|
|||||||||||
|
Exact Sciences Corp
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
BCRX, EXAS
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
|
|||||||||
|
Exact Sciences Corp
NASDAQ:EXAS
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
BioCryst Pharmaceuticals Inc | ||||
|
Exact Sciences Corp | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
BioCryst Pharmaceuticals Inc | ||||
|
Exact Sciences Corp | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
BioCryst Pharmaceuticals Inc | ||||
|
Exact Sciences Corp | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
BioCryst Pharmaceuticals Inc | ||||
|
Exact Sciences Corp | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
BioCryst Pharmaceuticals Inc | ||||
|
Exact Sciences Corp | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
BioCryst Pharmaceuticals Inc | ||||
|
Exact Sciences Corp | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
BioCryst Pharmaceuticals Inc | ||||
|
Exact Sciences Corp | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
BioCryst Pharmaceuticals Inc | ||||
|
Exact Sciences Corp | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
BCRX, EXAS
Performance By Year
BCRX, EXAS
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
|
| US |
S
|
Seagen Inc
F:SGT
|